Deutsche Bank AG Purchases Shares of 2,071,642 Baxter International Inc. $BAX

Key Points

• Deutsche Bank acquired 2.07 million Baxter shares in the second quarter, valued at approximately $44.2 million, giving it a 0.40% stake. Institutional investors and hedge funds collectively own 90.19% of the company.
• Baxter reported quarterly EPS of $0.56, beating the $0.37 consensus estimate, while revenue reached $2.96 billion and grew 5.3% year over year. The company maintained fiscal 2026 EPS guidance of $1.95–$2.15.
• Analyst sentiment remains generally cautious, with an average rating of “Hold” and an average price target of $22.45, despite several firms raising their targets. Shares opened at $26.37, up from a 200-day moving average of $20.36.

Deutsche Bank AG acquired a new stake in shares of Baxter International Inc. (NYSE:BAX - Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 2,071,642 shares of the medical instruments supplier's stock, valued at approximately $44,167,000. Deutsche Bank AG owned 0.40% of Baxter International as of its most recent SEC filing.

Other institutional investors and hedge funds have also made changes to their positions in the company. Covestor Ltd boosted its holdings in Baxter International by 9.5% in the fourth quarter. Covestor Ltd now owns 8,014 shares of the medical instruments supplier's stock valued at $153,000 after acquiring an additional 695 shares during the last quarter. Bruce G. Allen Investments LLC increased its stake in Baxter International by 22.8% during the fourth quarter. Bruce G. Allen Investments LLC now owns 4,452 shares of the medical instruments supplier's stock worth $85,000 after acquiring an additional 827 shares during the last quarter. Jump Financial LLC increased its stake in Baxter International by 5.7% during the fourth quarter. Jump Financial LLC now owns 15,968 shares of the medical instruments supplier's stock worth $305,000 after acquiring an additional 854 shares during the last quarter. Nicholas Hoffman & Company LLC. raised its holdings in shares of Baxter International by 2.1% in the 4th quarter. Nicholas Hoffman & Company LLC. now owns 46,913 shares of the medical instruments supplier's stock worth $897,000 after purchasing an additional 943 shares during the period. Finally, LRI Investments LLC raised its holdings in shares of Baxter International by 48.2% in the 4th quarter. LRI Investments LLC now owns 3,006 shares of the medical instruments supplier's stock worth $57,000 after purchasing an additional 978 shares during the period. 90.19% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

BAX has been the subject of several recent research reports. Wells Fargo & Company increased their price objective on shares of Baxter International from $19.00 to $23.00 and gave the stock an "equal weight" rating in a research report on Friday, July 31st. Wall Street Zen upgraded Baxter International from a "hold" rating to a "buy" rating in a report on Saturday, August 1st. UBS Group boosted their price objective on Baxter International from $19.00 to $25.00 and gave the company a "hold" rating in a research report on Tuesday, July 28th. Stifel Nicolaus upped their target price on shares of Baxter International from $19.00 to $24.00 and gave the stock a "hold" rating in a research report on Tuesday, July 28th. Finally, Citigroup upgraded shares of Baxter International from a "sell" rating to a "neutral" rating and lifted their price objective for the company from $17.00 to $28.00 in a research note on Friday, July 31st. Two research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat.com, the stock has an average rating of "Hold" and an average target price of $22.45.

Baxter International Trading Down 0.2%

Shares of NYSE BAX opened at $26.37 on Friday. Baxter International Inc. has a one year low of $15.73 and a one year high of $30.00. The firm has a market capitalization of $13.63 billion, a PE ratio of -12.74, a PEG ratio of 3.99 and a beta of 0.60. The company has a current ratio of 1.95, a quick ratio of 1.32 and a debt-to-equity ratio of 1.39. The business has a 50-day moving average price of $23.62 and a two-hundred day moving average price of $20.36.

Baxter International (NYSE:BAX - Get Free Report) last issued its earnings results on Thursday, July 30th. The medical instruments supplier reported $0.56 earnings per share for the quarter, beating analysts' consensus estimates of $0.37 by $0.19. The company had revenue of $2.96 billion for the quarter, compared to the consensus estimate of $2.80 billion. Baxter International had a positive return on equity of 16.57% and a negative net margin of 9.27%.The firm's quarterly revenue was up 5.3% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.59 EPS. Baxter International has set its FY 2026 guidance at 1.950-2.150 EPS. As a group, analysts predict that Baxter International Inc. will post 2.04 earnings per share for the current fiscal year.

Baxter International Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, October 1st. Shareholders of record on Friday, August 28th will be paid a dividend of $0.01 per share. The ex-dividend date of this dividend is Friday, August 28th. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.2%. Baxter International's dividend payout ratio (DPR) is -1.93%.

Baxter International Profile

Baxter International Inc is a global healthcare company that develops, manufactures and markets a broad portfolio of medical products, pharmaceutical therapies and biotechnology-based solutions. The company's primary business activities are organized around renal care, medication delivery, acute therapies, pharmacy automation, surgical care and biotechnology. Baxter's offerings are designed to support patient care in hospitals, dialysis centers, nursing homes and other healthcare facilities worldwide.

In the renal care segment, Baxter provides hemodialysis and peritoneal dialysis systems, water treatment equipment and related disposables, including dialyzers, bloodlines and catheters.

Want to see what other hedge funds are holding BAX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Baxter International Inc. (NYSE:BAX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source